EPINEPHRINE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Epinephrine (autoinjector) patents expire, and what generic alternatives are available?
Epinephrine (autoinjector) is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in EPINEPHRINE (AUTOINJECTOR) is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Epinephrine (autoinjector)
A generic version of EPINEPHRINE (AUTOINJECTOR) was approved as epinephrine by BPI LABS on July 29th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EPINEPHRINE (AUTOINJECTOR)?
- What are the global sales for EPINEPHRINE (AUTOINJECTOR)?
- What is Average Wholesale Price for EPINEPHRINE (AUTOINJECTOR)?
Summary for EPINEPHRINE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,295 |
| DailyMed Link: | EPINEPHRINE (AUTOINJECTOR) at DailyMed |
-patent-expirations.png "EPINEPHRINE (AUTOINJECTOR) drug patent expirations")
Recent Clinical Trials for EPINEPHRINE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lawson Health Research Institute | Phase 2/Phase 3 |
| Miltenyi Biomedicine GmbH | Phase 4 |
| Carsten Bindslev-Jensen | Phase 4 |
Pharmacology for EPINEPHRINE (AUTOINJECTOR)
| Drug Class | Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
US Patents and Regulatory Information for EPINEPHRINE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | EPINEPHRINE (AUTOINJECTOR) | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 090589-002 | Aug 16, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | EPINEPHRINE (AUTOINJECTOR) | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 090589-001 | Aug 16, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
